AGD President-Elect Testified on Amalgam at FDA Hearing
“While much of the testimony and literature is usually focused on the scientific aspects of the safety of dental amalgam, in the end, it all comes down to two people – the practicing dentist and the patient, who places his or her trust in their dentist,” testified Dr. Mayher.
The hearing was preceded by the FDA’s conclusion, after reviewing 34 research studies, that there has been no significant new information that would change its determination that mercury-based fillings do not harm patients, except in the rare case of an allergic reaction. Numerous other witnesses at the hearing agreed with the FDA’s conclusion.
Dr. Mayher stressed that credible institutions and federal agencies have “validated the safety of dental amalgam, time and time again, aided by many years of research.” He added that, “I have placed amalgams in my immediate family members’ mouths in the past, and I would not hesitate to do so in the future.”
Amalgam is safe to use and performs better than any other restorative material when placed in a moist environment. Further, many alternative treatments, such as crown and bridge work or gold onlays, are prohibitively more expensive and may not be an option for some patients. Therefore, using this restorative material is a matter of choice for the consumer – the patient.
“Until such time as amalgam, or any other restorative material previously approved for use in this country, is determined by credible sources to have detrimental effects on a patient’s health, and on society, the decision whether or not to place this material should be made by educated consumers under the guidance of his or her dentist,” concluded Dr. Mayher.
SOURCE: Academy of General Dentistry
[
Printer-friendly page ]




